SJS Investment Consulting’s Axsome Therapeutics AXSM Stock Holding History

SJS Investment Consulting’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$735	Buy	+3	New	+$651	﹤0.01%	2130

Other funds holding AXSM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SJS Investment Consulting's AXSM Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 3 shares worth $735. The stake represents ﹤0.01% of the portfolio and ranks #2130 among its holdings.

96 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

SJS Investment Consulting held 3 shares of Axsome Therapeutics worth $735 as of Q2 2026.
Axsome Therapeutics was a new SJS Investment Consulting position in Q2 2026.
Axsome Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2130 holding.
96 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.